Fig. 4From: The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse modelSerial bone marrow transplantation assays. At 2 months after secondary transplantation, the chimerism of total blood cells (a) B cells (b) T cells (c) and myeloid cells (d) in the peripheral blood of recipients receiving Asxl1 tm/+ cells declined faster than wild-type donors. *p < 0.05Back to article page